DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology

Diagnos, a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the signing of a contract with Óptica Central, the third largest optical chain store in Costa Rica for implementation of CARA across Costa Rica.

Recommended AI News: FlowBank Puts Global Markets at Investors Fingertips

“Óptica Central, in collaboration with Aselcom, DIAGNOS’ distributor, are pleased to start screening the population across our optical stores by providing DIAGNOS’ proven AI solution for early detection of eye illnesses, such as Diabetic Retinopathy, as well as preventing blindness caused by diabetes.   There is no doubt that DIAGNOS’ experience in Costa Rica, and in other Latin American countries, has been at the forefront in proving its service with their remarkable technology,” said Mr. Jefrey Salas, CEO of Óptica Central.

Recommended AI News: Green Hills Software Expands Advanced Development Tools for Leading Global Automotive Tier 1 Suppliers Using Infineon TRAVEO II

“At DIAGNOS we have made our mark in different parts of the world, in collaboration with our partners and different stakeholders, where our AI technology and experience for serving patients has set the standard. We know that Diabetic Retinopathy has become the main cause of blindness worldwide occurring in patients aged 20-64 years. Costa Rica is no different from other countries, with almost 15% of its population over 20 having diabetes, with less than 11% diagnosed. At least 35% have been identified with Diabetic Retinopathy within the diabetic population and 10% are in jeopardy of having severe retinopathy that will affect their vision. Our technology is helping now, through Óptica Central, to fill this gap,” said Mr. Andre Larente, President of DIAGNOS.

Recommended AI News: DATIS to Host Virtual Workforce Management Summit for Human Services Leaders